Edgewise Therapeutics Files Proxy Statement Supplement
Ticker: EWTX · Form: DEFA14A · Filed: May 14, 2025 · CIK: 1710072
| Field | Detail |
|---|---|
| Company | Edgewise Therapeutics, Inc. (EWTX) |
| Form Type | DEFA14A |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy, annual-meeting, supplemental-filing
Related Tickers: EWTX
TL;DR
Edgewise Therapeutics dropped a proxy supplement for the June 13th shareholder meeting. Check it out.
AI Summary
Edgewise Therapeutics, Inc. filed a supplemental proxy statement on May 14, 2025, regarding its Annual Meeting of Stockholders scheduled for June 13, 2025. This filing supplements the definitive proxy statement originally dated April 29, 2025, providing additional information to shareholders before the meeting.
Why It Matters
This filing provides shareholders with updated or additional information relevant to their voting decisions at the upcoming annual meeting, ensuring they have the most current details.
Risk Assessment
Risk Level: low — This is a routine proxy filing supplement, not indicating any immediate financial or operational risks.
Key Players & Entities
- Edgewise Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Filing date of the supplement
- June 13, 2025 (date) — Date of the Annual Meeting of Stockholders
- April 29, 2025 (date) — Date of the original definitive proxy statement
FAQ
What is the purpose of this DEFA14A filing?
This filing is a supplement to the definitive proxy statement of Edgewise Therapeutics, Inc., dated April 29, 2025, providing additional information for the Annual Meeting of Stockholders to be held on June 13, 2025.
When is the Annual Meeting of Stockholders for Edgewise Therapeutics, Inc.?
The Annual Meeting of Stockholders is scheduled to be held on June 13, 2025.
What is the filing date of this supplemental proxy statement?
This supplemental proxy statement was filed on May 14, 2025.
What was the date of the original definitive proxy statement?
The original definitive proxy statement was dated April 29, 2025.
Is this a preliminary or definitive proxy statement?
This is a supplement to the definitive proxy statement.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 14, 2025 regarding Edgewise Therapeutics, Inc. (EWTX).